A team is only as strong as its leadership. Our commitment to helping families starts at the top with our executives.
Chief Executive OfficerGeoff Crouse joined CBR as CEO in September 2012. He previously served as Chief Operating Officer at Immucor, a publicly traded global in vitro diagnostics company that was sold to TPG in 2011. Prior to Immucor, he served as vice president of the life sciences business at Millipore Corporation, a NYSE-traded provider of technologies, tools and services for the global life science industry. In this role, he led the Life Science Strategic Business Unit, a global laboratory consumables and reagents business. Prior to joining Millipore, he worked at Roche, a leader in the pharmaceuticals and diagnostics industries, where he led market development and government affairs for the diagnostics division based in Basel, Switzerland. Mr. Crouse earned a B.A. from Boston College and an M.B.A. and Masters of Public Health from the University of California at Berkeley.
Chief Financial Officer
Mike Johnson joined CBR as CFO in January 2013. Mike was most recently the CFO of Fenwal, a global blood technology company dedicated to supporting transfusion medicine and cell therapies. Mike successfully managed a carve-out of the Fenwal business from Baxter in 2006. From 2006 to 2012 Mike led the global finance and IT organizations through a business transformation that supported international integration of a stand-alone business and resulted in significant value creation. TPG, a large private equity firm, recently sold the business to Fresenius. Prior to Fenwal, Mike spent almost 10 years in senior financial roles at Dade Behring, a leading medical diagnostics company, including Corporate Controller, and V.P. Finance for the manufacturing, supply chain and R&D organizations. He brings a wealth of experience in finance, private equity, IT/IS, quality systems, and supply chain management in complex global businesses.
Vice President, Scientific and Medical Affairs
Heather Brown has been with CBR since 2001 and has more than 20 years of clinical and business experience in the healthcare and biotech industries. Heather is a board certified genetic counselor with extensive experience in prenatal, pediatric, and cancer genetics. She has led a number of new business development and healthcare marketing initiatives during her tenure at CBR. In her current role, she is primarily responsible for research partnerships, clinical trial management, and medical need-based programs. Heather holds a B.A. and M.S. in Health and Medical Sciences from the University of California at Berkeley.
Vice President, Laboratory Operations
Kristen Swingle has been responsible for overseeing all operations at CBR’s laboratory in Tucson, Arizona, since 2007. Kristen has a strong background in experimental design, technical writing, and management. In 2006, she served as the project lead for the implementation of AXP processing at CBR, working closely with Thermogenesis to optimize this process for our facility. Before coming to CBR, Kristen held the position of Microbiology Lab Manager for an environmental testing laboratory. Kristen holds a B.S. in Biology and a M.S. in Medical Sciences.